Israel Englander’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,000
Closed -$433K 5820
2025
Q1
$433K Buy
+4,000
New +$348K ﹤0.01% 4899
2024
Q3
Sell
-28,000
Closed -$4.58M 6047
2024
Q2
$4.58M Buy
+28,000
New +$3.99M ﹤0.01% 2807
2023
Q4
Sell
-4,000
Closed -$1.78M 6025
2023
Q3
$1.78M Buy
4,000
+2,448
+158% +$1.11M ﹤0.01% 3672
2023
Q2
$673K Sell
1,552
-3,432
-69% -$1.93M ﹤0.01% 4335
2023
Q1
$2.96M Buy
+4,984
New +$2.79M ﹤0.01% 3062

Other funds holding AGL

Israel Englander's AGL Position: Q2 2026 in Review

Israel Englander opened a new position in Agilon Health (AGL) in Q2 2026: 33,817 shares worth $3.62M. The stake represents ﹤0.01% of the portfolio and ranks #3309 among its holdings. This is a return to the name: Israel Englander previously reported a position in AGL as recently as Q4 2025.

Israel Englander first reported a position in AGL in Q3 2021 and has held it in 17 quarters since. The position peaked at $25.6M in Q4 2023. 180 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Israel Englander held 33,817 shares of Agilon Health worth $3.62M as of Q2 2026.
  • Agilon Health was a new Israel Englander position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3309 holding.
  • Israel Englander first reported a position in Agilon Health in Q3 2021 and has held it in 17 quarters since.
  • Israel Englander's Agilon Health position peaked at $25.6M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.